Glycosaminoglycans (GAGs), large anionic glycopolymers, are the glycan portion of proteoglycans and are important components of the extracellular matrix. Recently we reported that polysialic acid, a polyanionic glycopolymer specific to the brain, binds neurotrophic factors to form a large complex. It is not clear whether GAGs also bind neurotrophic factors to form a large complex. In the present study, we demonstrate that a brain-derived neurotrophic factor (BDNF) dimer directly binds GAGs other than chondroitin and hyaluronic acid to form a large complex. Neurotrophin-3 showed similar GAG binding properties. Furthermore, BDNF, after forming a large complex with GAG, bound to the BDNF receptors tropomyosin-related kinase (Trk) B and p75 neurotrophin receptor (NTR). These findings suggest that GAGs function to produce a reservoir of BDNF and other neurotrophic factors, and may serve to regulate their local concentrations on the cell surface.
Neurotrophins comprise a large family of dimeric polypeptides, including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and NT-4. Neurotrophins are involved in neuronal survival and differentiation during development and have vital roles in maintaining neuronal function in homeostasis as well as in neuronal regeneration. 1) Neurotrophins selectively interact with two types of receptors on the cell surface to transduce their signals into the cells, the low affinity neurotrophin receptor p75NTR and the high affinity protein-kinase receptors of tropomyosin-related kinase (Trk).
2) Among these neurotrophins, BDNF is the most abundant in the brain. It promotes the growth and development of immature neurons and enhances the survival and function of adult neurons through its receptors, TrkB and p75NTR. It is involved in several disorders, including depression, epilepsy, bipolar disorder, Parkinson's disease, and Alzheimer's disease. 3, 4) BDNF binds to polysialic acid, the major posttranslational modification of neural cell adhesion molecule (NCAM). 5) Polysialic acid (polySia, (! 8Sia2 !) n ) is a polymerized structure of sialic acid. NCAM modified with a polySia chain has been well studied in the nervous system because the modification of polySiachains is spatio-temporally regulated. PolySia is expressed in embryonic brains during neural differentiation and for the most part disappears in adult brains, although NCAM expression levels remain unchanged. Based on its bulky polyanionic nature, polySia on NCAM is thought to function as an anti-adhesive molecule against cell-cell/extracellular matrix interactions. 6, 7) We previously demonstrated that BDNF interacts with polySia, forming a large complex. The BDNF dimer is then transferred to its receptors from the large complex. Based on these findings, we proposed a new function for polySia as a reservoir or regulator of the concentration of these molecules. The mechanism underlying the formation of the BDNF and polySia complex remains unclear, but the polyanionic nature of polySia may be involved in its interactions with basic neurotrophins. 5) Hence, in this study we focused on polyanionic glycopolymers other than polySia in the brain, i.e., glycosaminoglycans (GAGs).
GAGs, sequentially linear glycans that consist of repeating particular disaccharide units composed of an N-acetylated or N-sulfated hexosamine and either a uronic acid or galactose, is the glycan portion of proteoglycans. 8) GAGs are classified into hyaluronic acid (HA), chondroitin (CH), chondroitin sulfate (CS), dermatan sulfate (DS), heparan sulfate/heparin (HS), and keratan sulfate (KS), based on differences in the repeating units. Except for HA and CH, these molecules are modified by sulfation. Some proteoglycans expressed in the brain are modified with CS, DS, and HS chains. 9) Direct interactions between neurotrophins and a series of GAGs, however, have not been examined. We hypothesize that GAGs, like polySia, directly bind to neurotrophins to form a large complex that functions as a reservoir of neurotrophins to maintain an efficient supply to the neurotrophin receptors. To test this hypothesis, we examined to determine whether direct binding of GAG and BDNF occurs under physiological conditions. We also characterized the BDNF-HS and BDNF-CS complexes in terms of their binding to TrkB and p75NTR.
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Materials and Methods
Materials. BDNF was purchased from PeproTech (Rocky Hill, NJ). NT-3 was from MBL (Nagoya, Japan). GAGs were from Seikagaku (Tokyo, Japan). The structure and molecular weight of the GAGs used here are summarized in Table 1 . Recombinant human TrkB/Fc chimera and p75NTR/Fc chimera containing (His) 6 -tag were obtained from RSD Systems (Minneapolis, MN). Rabbit anti-BDNF, anti-NT-3, anti-His antibodies, rabbit anti-TrkB and goat anti-p75NTR antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). Sephacryl S-300 and molecular weight markers for gel filtration (thyroglobulin (670 kDa), ferritin (440 kDa), catalase (230 kDa), lactate dehydrogenase (140 kDa), bovine serum albumin (BSA; 67 kDa), and cytochrome c (12 kDa)) were from General Electric (Piscataway, NJ). Polyvinylidene difluoride (PVDF) membrane (Immobilon P) was from Millipore (Bedford, MA). Prestained molecular weight markers, Bio-gel P-100, and Flamingo gel stain were from Bio-Rad (Hercules, CA). Colominic acid (polySia) was from Wako (Osaka, Japan). The polySia used in this study was identical to the polySia on NCAM in vertebrate brains.
5)
Horizontal native. PAGE-BDNF (100 ng) in 50 mM Tris-HCl (pH7.5) containing 0.15 M NaCl was incubated with or without GAGs (0-1 mg) at 37 C for 0 to 2 h. NT-3 (100 ng) was also incubated with GAGs. Samples were subjected to horizontal native-PAGE, followed by blotting onto PVDF membranes. We determined the EC50 value as described previously.
5) Briefly, we measured the amount of BDNF remaining in the cathode region densitometrically, and EC50 was calculated as the half concentration of the molecule that titrated 100 ng of BDNF.
Immunostaining. PVDF membranes were blocked with phosphatebuffered saline (PBS) or 50 mM Tris-HCl (pH 8.0) containing 150 mM NaCl (TBS) containing 0.05% Tween 20 and 1% bovine serum albumin or 2% skim-milk at 25
C for 1 h. The membrane was incubated overnight with the primary antibody, rabbit polyclonal anti-BDNF antibodies (0.2 mg/ml), anti-NT-3 antibodies (0.2 mg/ml), antiTrkB antibodies (0.2 mg/ml), anti-p75NTR antibodies (0.2 mg/ml), and anti-His antibodies (0.2 mg/ml) at 4 C. As the secondary antibody, peroxidase-conjugated anti-rabbit IgG antibodies (1/4,000 dilution) or anti-goat antibodies (1/2,000 dilution) were used at 37 C for 60 min, and color development was performed as previously described.
Crosslinking. BDNF (40 ng) was incubated with or without glycosaminoglycan (2 mg) or (8 ml of total volume) at 37
C for 2 h. The proteins were crosslinked by adding 1 ml of 2.5 mM disuccinimidyl suberate (DSS; Pierce Chemical, Rockford, IL) to the sample and incubating at 37 C for 30 min. After the reaction was stopped by adding 1 ml of 0.5 M Tris-HCl (pH 7.5) to the sample, BDNF was analyzed by SDS-PAGE and Western blotting with anti-BDNF antibodies.
Gel-filtration of BDNF and glycosaminoglycan complex with neurotrophin receptors. BDNF (2 mg) and heparan sulfate (HS) or chondroitin sulfate E (CS) (apparent molecular mass, >69 kDa) (400 mg) with or without neurotrophin receptors (TrkB and/or p75NTR) (2 mg) at 37 C for 2 h were subjected to Sephacryl S-300 chromatography (0:58 Â 28 cm, TBS). The eluents were analyzed by SDS-PAGE and Western-blot analysis using anti-BDNF antibody and anti-His, anti-TrkB, or anti-p75NTR antibody for TrkB or p75NTR.
Biacore analysis. A BDNF sensor chip was prepared by immobilization of BDNF (ÁRU 2659) on a research-grade CM 5 chip (Biosensor AB, Uppsala, Sweden) through its primary amino groups using EDC/NHS according to the standard amine coupling protocol. Following activation with EDC/NHS, successful immobilization of BDNF was achieved by diluting BDNF to 5 mg/ml in 10 mM sodium acetate buffer (pH 5.0). Interactions were characterized using a Biacore 2000 instrument (Biosensor AB). For BDNF/glycopolymer interactions, various concentrations of analytes (HS and polysialic acid) in HBS-EP buffer (0.01 M HEPES, 0.15 M NaCl, 3 mM EDTA, 0.005% polysorbate 20 v/v), pH 7.4) were injected over the BDNF sensor chip at a flow rate of 20 ml/min. At the end of each sample injection (120 s), HBS-EP buffer was passed over the sensor surface to monitor the dissociation phase. Following 180 s of dissociation, the sensor surface was fully regenerated by injection of 10 ml of 3 M NaCl. Levels of non-specific binding for each set of interactions were low and did not exceed 20% of the maximum RU value obtained in each interaction study. The Kd, ka, kd values were estimated by two or three independent experiments.
Results and Discussion
To demonstrate direct binding between various GAGs and BDNF, we first performed horizontal native-polyacrylamide gel electrophoresis (PAGE).
5) BDNF migrated toward the cathode region only because of its basic isoelectric point (pI 10.5; Fig. 1 , BDNF). After preincubation with polySia, BDNF acquired a negative charge and migrated toward the anode region ( Fig. 1 , BDNF+polySia). 5 We then analyzed the interaction between various GAGs (Table 1) and BDNF. Of those tested, CH and HA, which are also anionic polymers due to their uronic acids (GlcA and IdoA), did not interact with BDNF (Fig. 1B) . These findings indicate that not all anionic glycopolymers bind BDNF. On the other hand, CS4, CS6, DS, HS, KS, KPS, and HP all migrated toward the anode region, indicating that they directly interacted with BDNF (Fig. 1B) . Analysis of the binding ability of another neurotrophin, NT-3, with GAGs indicated that NT-3 also interacted with various GAGs, but not HA or CH (Fig. 1C) .
To evaluate the binding affinity of BDNF toward various GAGs, we estimated the EC50, which reflects binding affinity between proteins and glycopolymers. 5) The EC50 value was defined as the concentration of glycopolymer in 5 ml of reaction mixture that could titrate half of 100 ng of BDNF, and we calculated the glycopolymer concentration by immunostaining the BDNF remaining in the cathode region.
5) The EC50 of polySia binding with BDNF was estimated to be 9 ng/ml ( Table 2) . 5) CH did not titrate the BDNF at up to 200 ng/ml ( Fig. 2A) . HS and CS4 titrated the BDNF (Fig. 2B, C) , like the other GAGs tested (data not shown). The EC50s of all the GAGs, estimated by horizontal native PAGE under the same conditions, are summarized in Table 2 . The molecular weights of the polymers were analyzed by gel-filtration (Table 1) and EC50 was also calculated as a concentration. CH and HA contain disaccharide units, GlcA1,3GalNAc1,4 and GlcA1,3GlcNAc1,4, and did not titrate BDNF. These two glycopolymers have one carbohydrate with periodically distributed negative ions. On the other hand, polySia contains one carboxyl group in every monosaccharide residue. These sequential negative charges might be required for BDNF binding because the minimum chain length of polySia was determined to be 12. 5) It is also possible that binding BDNF requires a specific conformational structure of the glycopolymer. PolySia, whose degree of polymerization is greater than 8, can exist in a helical conformation, 10) whereas the conformation of the HA is a random coil.
11) The EC50 of polySia was 0.15 mM, as estimated with the molecular weight calculated by gel-filtration (Table 2) . 5) Other sulfated GAGs have EC50 values ranging from 0.047 to1.92 mM. These values indicate that sulfated GAGs and polySia have almost the same ability to hold neurotrophins under static conditions. Sulfated GAGs other than KS have sequential negative charges in their chains (Table 1) , and the conformation of HS is reported to be in part a helical structure, although the overall sequences are so heterogeneous that we cannot understand the molecule as a whole. KS has one carbohydrate with periodically distributed negative ions like HA and CH, but KS can titrate BDNF, although the K D value was one order of magnitude higher than those of other sulfated GAGs, and under some conditions not all the NT-3 was titrated with KS (Fig. 1C) . These findings might be due to differences between the carboxyl group (weak acid) and the sulfate group (strong acid). KPS, which has sequential negative charges (Table 2 ) due to additional sulfation of KS, reduced the EC50 value by 10%. In regard to the interaction between BDNF and GAGs, seven amino acids in C-terminal region of BDNF are highly conserved among the neurotrophin group, and this region might have a pivotal role in binding with anionic glycopolymers such as polySia and GAGs.
The horizontal native-PAGE method measures the binding of neurotrophins with glycopolymers under static conditions. Therefore, we also measured the binding strength between neurotrophins and glycopolymers by a surface plasmon resonance method with a Biacore system. In the Biacore system, glycopolymers flow past BDNF on the sensor chip at 20 ml/min. Thus the interaction occurs under flow conditions. The K D value of HS toward BDNF was 1:5 Â 10 À9 (M) and that of polySia was 9:1 Â 10 À6 (M), indicating that HS has higher affinity toward BDNF than does polySia ( Table 3 ). The affinity of HS toward BDNF was almost the same as that of polySia under static conditions ( Table 2) . HS is often found in the epithelial cells of vessels 12) and some neurotrophins such as BDNF are A, horizontal native-PAGE. BDNF (100 ng) incubated with polySia (BDNF þ polySia) or Neu5Ac (BDNF þ Neu5Ac) or without sialic acid (BDNF) at 37 C for 2 h in TBS was subjected to native PAGE. PolySia (polySia) alone was also subjected to the gel. BDNF was visualized by fluorescent staining. B, Binding between BDNF and various GAGs. BDNF (100 ng) incubated with 2 mg of polySia, CH, HA, CS4, CS6, DS, HS, KS, KPS, and HP (see Table 1 ) at 37 C for 2 h in TBS was subjected to native PAGE. After blotting onto the PVDF membrane, BDNF was visualized with anti-BDNF antibodies. C, Binding between NT-3 and various GAGs. BDNF (100 ng) incubated with 2 mg of polySia, CH, HA, CS4, CS6, DS, HS, KS, KPS, and HP (see Table 1 ) at 37 C for 2 h in TBS was subjected to native PAGE. After blotting onto the PVDF membrane, BDNF was visualized with anti-BDNF antibodies. Arrowhead, origin; À, cathode; þ. anode. detected in the serum. 13) Flow conditions in such tissues might force an interaction in such a way that GAGs capture such neurotrophins more effectively than does polySia.
To evaluate more precisely whether BDNF forms complexes with GAGs, we performed a gel chromatography analysis. BDNF (13.5 kDa) exists as a dimer under physiologic conditions and elutes at about 27 kDa on gel chromatography. 1) In the present study, BDNF eluted at about 27 kDa on Bio-gel P-100 chromatography (data not shown). Before analyzing the complex between BDNF and HS and that between BDNF and CS by gelfiltration, we cross-linked BDNF to determine whether the BDNF dimer makes a larger complex after incubation with GAGs. BDNF existed as a dimer before and after incubation with HS or CS (Fig. 3A , +DSS lanes, BDNF, BDNF/HS, BDNF/CS), as with polySia (BDNF/polySia; Fig. 3A) . We then analyzed complex formation between BDNF and HS and that between BDNF and CS by Sephacryl S-300 chromatography, because the polySia-BDNF complex was too large to be analyzed by Biogel-P-100 chromatography. After incubation with HS and with CS, elution of BDNF was observed in fractions 12-18 (Fig. 3B , BDNF/HS) and fractions [13] [14] [15] [16] [17] [18] (Fig. 3B , BDNF/CS), whereas the 670-kDa protein was eluted in fraction 15. The fact that BDNF existed as a dimer, even after incubation with HS and with CS based on the cross-linking experiment, indicates that HS and CS do not induce the oligomerization of BDNF, and that the BDNF dimer formed a large complex with HS and with CS. The HS and BDNF complex was larger than that of the BDNF and CS complex because the elution peak of the CS complex was retarded. According to the calibration of the Sephacryl S-300 gel, the complex between HS and BDNF was estimated to be 230 kDa-2400 kDa and that The amount of BDNF remaining in the cathode region was measured densitometrically. The broken line indicates the EC50 value (EC50 was defined as the concentration of the glycopolymer that can titrate half of the 100 ng of BDNF in TBS (total volume, 5 ml) as migration toward the anode region.
5) See also Table 2 . Arrowhead, origin; À, cathode; þ, anode. Table 3 . Affinity between BDNF-HS and BDNF-polySia Determined by Biacore Names of glycosaminoglycan 
À6
of CS to be 230 kDa-1600 kDa. The EC50 value of HS was 0.36 mM ( Table 2 ), indicating that the BDNF dimer (27 kDa) interacted with HS (11 kDa) at a molar ratio 1:1 (Fig. 3A) . Based on molecular weight calculations, BDNF and HS formed a larger complex (38 kDa per unit as we estimated the complex to be BDNF:HS = 1:1), and the complex was to be 6-63 units. On the other hand, BDNF and CS also formed a large complex, but no precise estimation could be done because the precise molecular weight of the CS we used in the gel filtration was unknown. Neurotrophins are involved in neural cell survival, axonal growth, synaptic plasticity, and neurotransmission via binding to their specific receptors. 1, 2) Recently, we demonstrated that part of a BDNF dimer in a BDNFpolySia complex can bind to BDNF receptors and that polySia functions as a neurotrophin-reservoir. 5) To investigate whether this is a common function between HS or CS and polySia, we analyzed the BDNF-HS and BDNF-CS complex with or without TrkB or p75NTR by Sephacryl S-300 chromatography. The recombinant Histagged Fc-chimera of the extracellular domain (aa 1-430) of human TrkB (140 kDa) and the recombinant His-tagged Fc chimera of the extracellular domain (aa 1-210) of human p75NTR (100 kDa) were used as test receptors. The ligand-receptor complexes were analyzed by Sephacryl S-300 chromatography (Figs. 4 and 5 ). BDNF and HS formed a large complex and eluted in fractions 12-18 on Sephacryl S-300 chromatography (Fig. 3B , BDNF/HS, IB: BDNF). TrkB existed as a dimer (280 kDa) and eluted in fractions 15-17 (Fig. 4A , TrkB, IB: His or TrkB). TrkB incubated with BDNF coeluted with BDNF in fractions 15-17, because BDNF was also detected at fractions 15-17 (Fig. 4A , BDNF/ TrkB, IB: BDNF), suggesting that TrkB binds to BDNF. Co-incubation with HS did not affect the elution profile of the TrkB receptor (Fig. 4A , HS/TrkB, IB: His or TrkB). We then determined whether BDNF binds to TrkB as a BDNF-HS complex. BDNF preincubated with HS to form the BDNF-HS complex was incubated with the TrkB receptor and subjected to Sephacryl S-300 chromatography. BDNF was detected not only as a BDNF-HS complex in fractions 13-20, but also as a C for 2 h and crosslinked by adding DSS to the sample. Crosslinked sample (þDSS) or non-crosslinked samples (ÀDSS) were analyzed by SDS-PAGE and Western blotting with anti-BDNF antibodies. B, Sephacryl S-300 chromatography of BDNF making complex with HS or with CS. BDNF (2 mg) incubated with HS (400 mg) (BDNF/HS) or CS (400 mg) (BDNF/CS) was subjected to Sephacryl S-300 chromatography (0:58 Â 28 cm, TBS). The samples collected were electrophoresed and analyzed by Western blotting using anti-BDNF antibodies. Elution of thyroglobulin (670 kDa) and BSA (67 kDa) is indicated. IB: His or TrkB]. To confirm these elution profiles quantitatively, we estimated the immunostaining of BDNF and TrkB densitometrically. The peak elution of BDNF that formed a complex with HS shifted to the lower molecular weight area near the TrkB peaks (Fig. 4B) , indicating that BDNF making complex with HS can move to the BDNF receptors and that a ternary complex might not be formed because the peak of TrkB did not move with or without HS incubation (Fig. 4B,  TrkB) . Similar results were obtained with recombinant p75NTR (Fig. 5A and B) . We also analyzed the CS and BDNF complex with and without TrkB or p75NTR and the results were similar to that for HS (data not shown). These findings together indicate that BDNF that makes BDNF-HS and BDNF-CS complexes can move to the BDNF receptors, TrkB and p75NTR, depending on their affinity toward the receptors, to exhibit biological functions. The K D values of BDNF À TrkB and BDNF-p75NTR are 0.01 nM and 1 nM, respectively. 14) In the present study, we estimated the EC50 as 360 nM under static conditions. These 2-to 4-order differences in the K D between HS and BDNF-receptors result in the transfer of BDNF from the HS to the receptors (Figs. 4 and 5). It is well established that proteoglycans containing HS enhance fibroblast growth factor (FGF)-driven proliferation through the formation of a stable ternary complex with HS, FGF, and the FGF-receptor. 15) In the present study, however, we demonstrated that BDNF does not form a ternary complex with HS or CS and BDNF receptors, and that BDNF and GAG form a large complex. These are the same features as those of polySia.
5) The mechanism underlying GAG involvement in growth factors might be different from that of GAG involvement in neurotrophins, although both molecules function by binding to their receptors. The apparent K D value of BDNF-HS under flow conditions was estimated by surface plasmon resonance to be 9 nM and affinity increased 36-fold as compared with that of BDNF-HS under static conditions. The K D value of BDNF-polySia and BDNF-HS was different under flow conditions, however, indicating that the functional mechanism of polySia is the catch and release of BDNF, and that GAG mechanisms differ depending on the microenvironment.
HS, CS, and KS bind not only BDNF, but also other neurotrophins such as NT-3. BDNF and NT-3 are expressed and function in a time-and space-dependent A, Sephacryl S-300 chromatography of the complex. BDNF (2 mg) was incubated with HS (400 mg) (BDNF/HS) (Fig. 3B) or TrkB (BDNF/ TrkB). In addition, after complex formation between BDNF (2 mg) and HS (400 mg), the samples were further incubated with TrkB ((BDNF/HS) þ TrkB). TrkB was also incubated with HS (TrkB/HS) or BDNF (TrkB/BDNF). Samples were subjected to the Sephacryl S-300 chromatography (0:58 Â 28 cm, eluted with TBS) and the proteins were collected. Eluted BDNF or His-tagged neurotrophin receptor ( manner. Like polySia, the expression of several proteoglycans that have specific GAGs is also spatio-temporal. 9) Therefore, GAGs such as HS, CS, and KS and polySia may function to produce a reservoir of these neurotrophins on the neural cell surface, as well as a regulator of the local concentration of neurotrophins by condensing them and inhibiting their diffusion. A, Sephacryl S-300 chromatography of the complex. BDNF (2 mg) was incubated with HS (400 mg) (BDNF/HS) (Fig. 3B ) or p75NTR (BDNF/p75NTR). In addition, after complex formation between BDNF (2 mg) and HS (400 mg), the samples were further incubated with p75NTR ((BDNF/HS) þ p75NTR). p75NTR was also incubated with HS (p75NTR/HS) or BDNF (p75NTR/BDNF). The samples were subjected to the Sephacryl S-300 chromatography (0:58 Â 28 cm, eluted with TBS) and the proteins were collected. Eluted BDNF or His-tagged neurotrophin receptor (p75NTR) was analyzed by Western blotting using anti-BDNF antibodies (IB: BDNF) or anti-His antibodies (IB: His or anti-p75NTR). Elution of thyroglobulin (670 kDa) and BSA (67 kDa) is indicated. P indicates His-tagged receptor as positive control. B, Elution profiles of Sephacryl S-300 chromatography. The concentrations of BDNF bands of BDNF/HS ( ) or (BDNF/HS) þ p75NTR ( ) observed with anti-BDNF antibody were calculated densitometrically (left panel, BDNF). The concentrations of p75NTR bands of p75NTR ( ), p75NTR/HS ( ), BDNF/p75NTR (Â), and (BDNF/HS) þ p75NTR ( ) observed with anti-His or anti-p75NTR antibody were calculated densitometrically (right panel, p75NTR).
